A delegation of prospective investors from US is likely to visit Orissa in phases from October to December this year to assess the state's investment climate so as to give a concrete shape to their......
Drug major Kopran has received approval from the US patent office for its new chemical entity (NCE) - KNC-6 filed in September 2001.KNC-6 is a novel dual action anti-ulcerant having significant......